Shanghai JinKui Medical Receives Approval for World’s First Self-Expanding, Single-Rivet, Bioabsorbable Atrial Septal Defect Occluder

• Equipment Composition:Composed of a mesh body, connectors, barrier membranes, and sutures;
• Scope of Application:For transcatheter minimally invasive interventional closure of atrial septal defects;
• Product Technical Features:Biodegradable atrial septal defect occluder with self-expanding shape-memory properties; simple clinical operation, expected to reduce mechanical injury to septal tissue, lower the incidence of arrhythmias, and enhance implantation safety for patients;
• Regulatory Note:The drug regulatory authorities will strengthen post-market supervision of this product to ensure the safety of patients using medical devices.

Shanghai Jinkui Medical Devices Co., Ltd. is an innovative enterprise in China dedicated to the research, development, and manufacturing of interventional devices for structural heart disease.Focusing on the minimally invasive treatment of congenital heart diseases, such as atrial septal defect and ventricular septal defect.Dedicated to driving technological breakthroughs and clinical application of domestically produced high-end interventional devices through independently developed biodegradable materials and innovative designs, providing safer and more effective treatment solutions for patients with cardiovascular diseases.